Lemborexant in insomnia disorder: a profile of its use Hannah A. Blair Adis Drug Q&A 09 May 2020 Pages: 427 - 434
Choose treatment for restless legs syndrome based on patient and drug characteristics Esther S. KimKatherine A. Lyseng-Williamson Disease Management 03 September 2020 Pages: 435 - 439
Intra-articular hyaluronic acids for osteoarthritis of the knee Micheline Andel GoldwireLeticia A. Shea Review Article 06 August 2020 Pages: 440 - 450
Strategies to conserve salbutamol pressurized metered-dose inhaler stock levels amid COVID-19 drug shortage Ali ElbeddiniYasamin TayefehchamaniLucy Yang Current Opinion 25 July 2020 Pages: 451 - 454
Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview Maria Auxiliadora Parreiras MartinsAmanda Fonseca de MedeirosAdriano Max Moreira Reis Current Opinion 31 July 2020 Pages: 455 - 462
Should community pharmacies provide COVID-19 screening services? Ching Siang Tan Commentary 14 August 2020 Pages: 463 - 465
Current burden on healthcare systems in low- and middle-income countries: recommendations for emergency care of COVID-19 Husnain HamidZubia AbidTooba Mehboob Commentary 09 August 2020 Pages: 466 - 468
Adverse drug reaction reporting in Canada: consumer versus physician reports Rania Al DweikDafna KohenSanni Yaya Original Research Article 04 August 2020 Pages: 469 - 475
Correction to: Adverse drug reaction reporting in Canada: consumer versus physician reports Rania Al DweikDafna KohenSanni Yaya Correction 14 August 2020 Pages: 476 - 476